» Authors » I Litvan

I Litvan

Explore the profile of I Litvan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 121
Citations 8056
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Casaletto K, Staffaroni A, Wolf A, Appleby B, Brushaber D, Coppola G, et al.
Alzheimers Dement . 2020 Jan; 16(1):91-105. PMID: 31914227
Introduction: Leisure activities impact brain aging and may be prevention targets. We characterized how physical and cognitive activities relate to brain health for the first time in autosomal dominant frontotemporal...
2.
Heuer H, Wang P, Rascovsky K, Wolf A, Appleby B, Bove J, et al.
Alzheimers Dement . 2020 Jan; 16(1):60-70. PMID: 31914226
Introduction: Behavioral variant frontotemporal dementia (bvFTD) may present sporadically or due to an autosomal dominant mutation. Characterization of both forms will improve understanding of the generalizability of assessments and treatments....
3.
Grunho M, Sonies B, Frattali C, Litvan I
Parkinsonism Relat Disord . 2015 Oct; 21(11):1342-8. PMID: 26456115
Objectives: To determine the characteristics of swallowing and speech disturbances in patients with corticobasal syndrome (CBS) compared to healthy controls, and whether a subjective swallowing questionnaire, the NIH-Speech Pathology swallowing...
4.
Armstrong M, Naglie G, Duff-Canning S, Meaney C, Gill D, Eslinger P, et al.
Dement Geriatr Cogn Dis Extra . 2012 Sep; 2(1):343-52. PMID: 22962558
Background/aims: The role of cognitive reserve in Parkinson's disease (PD)-mild cognitive impairment (MCI) is incompletely understood. Methods: The relationships between PD-MCI, years of education, and estimated premorbid IQ were examined...
5.
Goldman J, Litvan I
Minerva Med . 2011 Dec; 102(6):441-59. PMID: 22193376
Parkinson's disease (PD) traditionally has been defined by its characteristic motor hallmarks, but non-motor features such as cognitive impairment and dementia are increasingly recognized as part of PD. Mild cognitive...
6.
Uc E, McDermott M, Marder K, Anderson S, Litvan I, Como P, et al.
Neurology . 2009 Nov; 73(18):1469-77. PMID: 19884574
Objective: To investigate the incidence of and risk factors for cognitive impairment in a large, well-defined clinical trial cohort of patients with early Parkinson disease (PD). Methods: The Mini-Mental State...
7.
Ludolph A, Kassubek J, Landwehrmeyer B, Mandelkow E, Mandelkow E, Burn D, et al.
Eur J Neurol . 2009 Apr; 16(3):297-309. PMID: 19364361
Tauopathies with parkinsonism represent a spectrum of disease entities unified by the pathologic accumulation of hyperphosphorylated tau protein fragments within the central nervous system. These pathologic characteristics suggest shared pathogenetic...
8.
Wenning G, Litvan I, Verny M, Ray-Chaudhuri K, Granata R, Poewe W, et al.
Parkinsonism Relat Disord . 2008 Jul; 4(2):79-80. PMID: 18591093
No abstract available.
9.
Tobin J, Latourelle J, Lew M, Klein C, Suchowersky O, Shill H, et al.
Neurology . 2008 May; 71(1):28-34. PMID: 18509094
Background: Microtubule-associated protein tau (MAPT) has been associated with several neurodegenerative disorders including forms of parkinsonism and Parkinson disease (PD). We evaluated the association of the MAPT region with PD...
10.
Wilk J, Tobin J, Suchowersky O, Shill H, Klein C, Wooten G, et al.
Neurology . 2006 Dec; 67(12):2206-10. PMID: 17190945
Background: Polymorphisms in the glutathione S-transferase pi gene (GSTP1), encoding GSTP1-1, a detoxification enzyme, may increase the risk of Parkinson disease (PD) with exposure to pesticides. Using the GenePD Study...